DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Flare Capital Management Company, LLC
Flare Capital Management Company, LLC
Investing in exceptional founders transforming healthcare Our entrepreneurs are addressing important issues across the entire healthcare technology industry. our companies Dr. Michael Gao From seed to $1B+ in 3 years. Brooke boyarsky pratt & Dr. angela Fitch Weight-inclusive healthcare for all. Suki Punit Soni Founder & CEO Aetion Jeremy Rassen, Sc.D. Co-Founder and CEO Author […]
venture manager, reported GAV $1,032M across 4 vehicles
Importance
53
elevated
Active deployment
30
moderate
Emerging
0
low
Completeness
81
high
Freshness
100
high
Research priority
13
low
Identity and regulatory footprint
- Headquarters
- Boston, MAadviserinfo.sec.gov
- Office address
- 800 BOYLSTON STREET, SUITE 2310, Boston, MA, 02199adviserinfo.sec.gov
- Business phone
- 617-607-5060adviserinfo.sec.gov
- Website
- HTTP://WWW.FLARECAPITAL.COM
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- May 14, 2026
- Private funds reported
- 5 (5 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $945Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business email
- flare@flarecapital.comflarecapital.compublished by the subject
- business email
- flare@www.flarecapital.comflarecapital.compublished by the subject
- business phone
- 617-607-5060adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
41 observed deals
Stated (the firm’s website)
- Sectors
- ai, enterprise software, healthcare
- Stages
- seed
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series a 60%series b 20%series c 20%
Stage at first entry
series a 50%series b 25%series c 25%
Sectors
unknown 87%Other 5%Other Technology 5%Other Health Care 3%
lead rate 29%follow-on rate 17%new logos, 12 months 40
site says seed/early; 50% of first entries on record are Series B or later
Funds and vehicles
4 reported, 3 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Flare Capital Partners III, LP | Fund | 2022 form d first sale | Active deployment | $341M Mar 15, 2024 | 92 | $350M of $350M | Apr 25, 2022 |
| Flare Capital Partners II, L.P. | Fund | 2018 form d first sale | Harvest | $242M Mar 15, 2024 | 69 | $255M of $255M | Jul 22, 2019 |
| Flare Capital Partners I-A, L.P. | Feeder or parallel | 2017 adv first reported | Harvest | $50.4M Mar 15, 2024 | 2 | unknown | unknown |
| Foundation Medical Partners IV, L.P. | Fund | 2013 form d first sale | Harvest | $398M Mar 15, 2024 | 55 | $133M | Apr 16, 2015 |
| Foundation Medical Partners, L.P. | Fund | unknown | Wound down | $25.6M Mar 30, 2015 | 14 | unknown | unknown |
| Foundation Medical Partners III, L.P. | Fund | unknown | Wound down | $7.5M Mar 13, 2020 | 7 | unknown | unknown |
| Foundation Medical Partners II, L.P. | Fund | unknown | Wound down | $3.7M Mar 10, 2017 | 20 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
25 current, 6 departed
Michael Greeley
General partnerCo-Founder and General Partner
Caroline Glen
Investor relationsVice President of Investor Relations
Michael Alexander Greeley
Managing partnerManaging Member · since Oct 1, 2013
Michael Alexander Greeley
Managing partnerManaging Member · since Oct 1, 2013
Chris Hocevar
PartnerExecutive Partner
Dan Gebremedhin
PartnerPartner
Gary Gottlieb
PartnerExecutive Partner
Graham Gardner
PartnerExecutive Partner
Ian Chiang
PartnerPartner
Margaret Malone
PartnerPartner
Parth Desai
PartnerPartner
Phyllis Gotlib
PartnerExecutive Partner
Rochelle Walensky
PartnerExecutive Partner
Varsha Rao
PartnerExecutive Partner
Victor Lanio
PartnerPartner
Adam Bruce
Platform and operationsPartner, Chief Financial and Chief Operating Officer
Adam Bruce
Platform and operationsChief Financial Officer · since Aug 1, 2017
Adam Patrick Bruce
Platform and operationsChief Financial Officer · since Aug 1, 2017
Pam Walser
Platform and operationsController
Sophie Tapper
Platform and operationsExecutive Assistant
Tara Sullivan
PrincipalPrincipal
Tara Sullivan
PrincipalPrincipal
Alyssa Tsenter
Vice presidentSenior Associate
Jonathon George
Vice presidentVice President
Sara Hoffman
Vice presidentSenior Associate
6 departed (kept with end dates)
- Andrew David Firlik · Managing Member Of Applicant, Foundation Medical Managers Ii, Llc And Foundation Medical Managers Iii, Llc · Oct 1, 2013 to Mar 30, 2015 Inference
- Harry Rein · Managing Member Of Foundation Medical Managers Iii, Llc · Jul 1, 2008 to Jun 13, 2013 Inference
- LEE Robert Wrubel · Managing Member · Apr 1, 2001 to Mar 29, 2016 Inference
- William John Geary · Managing Member · Oct 1, 2013 to May 14, 2026 Fact
- Jonathan Michael D Cool · Member, Foundation Medical Managers, Llc · Apr 1, 2001 to Mar 30, 2015 Inference
- Kristen Lee Laguerre · Chief Financial Officer · Jun 1, 2015 to Nov 16, 2017 Inference
Investments on record
41 edges, 39 companies, 1 partner-attributed
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
30 relationships from shared deals, counted for the whole firm
TAU Ventures, LLC 3 shared · recurring · we led 1CVS Health Ventures 2 shared · recurringHealthier Capital, LLC 2 shared · recurring · they led 1Signalfire 2 shared · recurring · they led 1 · we led 1Frist Cressey Ventures 2 shared · recurringMeyer Keith Management, LLC 1 shared · one timeValuestream Ventures 1 shared · one timeEpsilon Health Investors, LLC 1 shared · one timeStageone Ventures 1 shared · one timeRegeneration.vc, LLC 1 shared · one timeDorm Room Fund 1 shared · one timeForum Ventures, LLC. 1 shared · one timeCity Light Capital Management III, LLC 1 shared · one timeBling Capital LLC 1 shared · one timeSempervirens Ventures LLC 1 shared · one time1st Course Capital Management, LLC 1 shared · one timeCourtside Ventures 1 shared · one timeThree-Sixty Health Venture Partners, LLC 1 shared · one timeAugment Ventures 1 shared · one timeIntandem Capital Partners, LLC 1 shared · one timePave Health Ventures 1 shared · one time · we led 1CRM 1 shared · one time · we led 1Costanoa Ventures 1 shared · one time · they led 1Notation Capital Management, LLC 1 shared · one timeGreatpoint Investment Management, LLC 1 shared · one timeTown Hall Ventures, LLC 1 shared · one timeCathay Innovation 1 shared · one timeGaingels 1 shared · one time · we led 1Alumni Ventures 1 shared · one time · we led 1Oak HC 1 shared · one time · they led 1
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
22 dated events
- Sep 16, 2026Kairon Health no longer listed on Flare Capital Management Company, LLC's portfolio pageRemoved from portfolio pagePortfolioInferenceKairon HealthVenture organization websites (about, team, portfolio, thesis, news pages)
- May 14, 2026William John Geary (Managing Member) no longer on Schedule A of Flare Capital Management Company, LLCPerson leftPeopleInferenceWilliam John GearyIAPD Form ADV Part 1 PDF per firm (current filing, Schedule D 7.B.(1) and Schedule A)
- Mar 18, 2022Flare Capital Partners III, LP first reported on Form ADV by Flare Capital Management Company, LLC (Venture Capital Fund), GAV $272,391,000Fund first reported on Form ADVFundsFactFlare Capital Partners III, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 2, 2021Foundation Medical Partners III, L.P. no longer reported on Form ADV by Flare Capital Management Company, LLCFund no longer reportedFundsInferenceFoundation Medical Partners III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 12, 2019Flare Capital Partners II, L.P. first reported on Form ADV by Flare Capital Management Company, LLC (Venture Capital Fund), GAV $197,623,000Fund first reported on Form ADVFundsFactFlare Capital Partners II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Nov 16, 2017Foundation Medical Partners II, L.P. no longer reported on Form ADV by Flare Capital Management Company, LLCFund no longer reportedFundsInferenceFoundation Medical Partners II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Nov 16, 2017Kristen Lee Laguerre (Chief Financial Officer) no longer on Schedule A of Flare Capital Management Company, LLC
- Aug 1, 2017Adam Bruce joined Schedule A of Flare Capital Management Company, LLC as Chief Financial Officer
- Mar 10, 2017Flare Capital Partners I-A, L.P. first reported on Form ADV by Flare Capital Management Company, LLC (Venture Capital Fund), GAV $24,560,936Fund first reported on Form ADVFundsFactFlare Capital Partners I-A, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2016LEE Robert Wrubel (Managing Member) no longer on Schedule A of Foundation Medical Partners
- Mar 29, 2016Foundation Medical Partners, L.P. no longer reported on Form ADV by Foundation Medical PartnersFund no longer reportedFundsInferenceFoundation Medical Partners, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 1, 2015Kristen Lee Laguerre joined Schedule A of Foundation Medical Partners as Chief Financial Officer
- Mar 30, 2015Jonathan Michael D Cool (Member, Foundation Medical Managers, Llc) no longer on Schedule A of Foundation Medical Partners
- Mar 30, 2015Andrew David Firlik (Managing Member Of Applicant, Foundation Medical Managers Ii, Llc And Foundation Medical Managers Iii, Llc) no longer on Schedule A of Foundation Medical Partners
- Mar 31, 2014Foundation Medical Partners IV, L.P. first reported on Form ADV by Foundation Medical Partners (Venture Capital Fund), GAV $83,501,684Fund first reported on Form ADVFundsFactFoundation Medical Partners IV, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Oct 1, 2013William John Geary joined Schedule A of Foundation Medical Partners as Managing Member Of Applicant, Foundation Medical Managers Iv, Llc
- Oct 1, 2013Michael Alexander Greeley joined Schedule A of Foundation Medical Partners as Managing Member Of Applicant, Foundation Medical Managers Iv, Llc
- Jun 13, 2013Harry Rein (Managing Member Of Foundation Medical Managers Iii, Llc) no longer on Schedule A of Foundation Medical Partners
- Mar 30, 2012Foundation Medical Partners III, L.P. first reported on Form ADV by Foundation Medical Partners (Venture Capital Fund), GAV $58,600,000Fund first reported on Form ADVFundsFactFoundation Medical Partners III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Foundation Medical Partners, L.P. first reported on Form ADV by Foundation Medical Partners (Venture Capital Fund), GAV $61,300,000Fund first reported on Form ADVFundsFactFoundation Medical Partners, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Foundation Medical Partners II, L.P. first reported on Form ADV by Foundation Medical Partners (Venture Capital Fund), GAV $95,700,000Fund first reported on Form ADVFundsFactFoundation Medical Partners II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Foundation Medical Partners first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $1,032M across 4 vehicles
Evidence
59 observations from 4 sources